Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Growth Metrics
Income Statement
Others
Ratios

Bioregenx (BRGX) Long-Term Debt Repayments (2024 - 2025)

Bioregenx's Long-Term Debt Repayments history spans 2 years, with the latest figure at $44142.0 for Q4 2025.

  • Quarterly results put Long-Term Debt Repayments at $44142.0 for Q4 2025, up 421.16% from a year ago — trailing twelve months through Dec 2025 was $114408.0 (up 137.16% YoY), and the annual figure for FY2025 was $114408.0, up 137.16%.
  • Long-Term Debt Repayments for Q4 2025 was $44142.0 at Bioregenx, down from $46674.0 in the prior quarter.
  • In the past five years, Long-Term Debt Repayments ranged from a high of $46674.0 in Q3 2025 to a low of $8470.0 in Q4 2024.